Imc-c225
Imc-c225 - Related Videos
08:21
Site-specific Bacterial Chromosome Engineering: ΦC31 Integrase Mediated Cassette Exchange (IMCE)
0 Views •
Cited by 11 •
2012
A quick and efficient method to integrate foreign DNA of interest into pre-made acceptor strains, termed landing pad strains, is described. The method allows site-specific integration of a DNA cassette into the engineered landing pad locus of a given strain, through conjugation and expression of the ΦC31 integrase.
01:08
IMC Budget I
0 Views •
2024
An Integrated Marketing Communications (IMC) budget is a comprehensive financial blueprint that outlines the projected costs for all promotional and marketing activities of a company. This budget encapsulates every channel and tactic that the business intends to use to communicate its message to customers, such as social media, email marketing, SEO, traditional advertising, and more. The IMC budget carries significant weight as it plays a crucial role in strategic planning, resource allocation,...
01:21
IMC Budget II
0 Views •
2024
The Integrated Marketing Communications (IMC) budget holds paramount importance in a company's marketing strategy. A financial blueprint that allocates resources for promotional activities, ensuring every dollar spent contributes to achieving business objectives and efficiently maximizing investments. Firstly, the IMC budget aids strategic planning. Outlining the cost of each promotional activity assists in defining clear marketing goals and strategies that align with the company's overall...
06:51
Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
0 Views •
2025
This protocol details a methodology for multiplex mRNA detection with protein imaging mass cytometry in formalin fixed paraffin embedded tissue sections.
FAQs
After IMC-C225 occupies EGFR’s extracellular region, epidermal growth factor and related ligands cannot activate the receptor in the usual way. The immediate consequence is reduced EGFR signaling, which matters because those signals support cellular proliferation and survival. Studying this sequence allows researchers to connect ligand-receptor interactions with biological processes associated with tumor progression.
Targeting the extracellular region positions IMC-C225 at the point where activating ligands interact with EGFR. This enables receptor activation to be interrupted at the cell surface, before ligand-driven signaling promotes growth-related responses. The mechanism provides a focused way to examine how events outside the cell influence intracellular signaling and broader biological behavior.
When a biological response depends on EGFR activity, blocking the receptor with IMC-C225 can help test whether EGFR-linked signaling contributes to that response. Changes in signaling, proliferation, or tumor-progression-related behavior can then be interpreted in relation to that dependency. The antibody therefore supports both targeted treatment research and investigation of receptor-specific mechanisms in cancer biology.
Relevant outcomes include the strength of receptor signaling and the resulting effects on cellular proliferation, survival, and tumor progression. These measures connect the molecular action of IMC-C225 with larger biological consequences. Considering several outcomes together helps researchers determine whether limiting EGFR activation is associated with broader changes in growth-regulating processes.
IMC-C225 has been developed in cancer research for colorectal tumors and head and neck tumors. These settings reflect the importance of examining EGFR-related growth and survival mechanisms in different tumor types. Its use across these areas also supports research into how a common receptor-targeting strategy may apply to distinct cancers.
IMC-C225 has been developed for use both as a targeted therapy and in combination with other treatments. This makes it relevant to research designs that examine EGFR-directed action alongside a second intervention, rather than treating receptor blockade as an isolated strategy. Combination studies place control of EGFR signaling within broader approaches to cancer treatment.